Companies such as AstraZeneca are also working on injectable drugs targeting the hormone amylin for enhanced weight-loss regimes, combining different drugs and medicines designed to preserve muscle mass
GLP-1 receptor agonists reduce appetite and food intake, potentially leading to micronutrient deficiencies rather than causing direct malabsorption
Starting dose is determined by your individual profile
In this article, well cover the most common side effects of phentermine, the rare but more serious risks, how they compare with GLP-1 medications, and what you can expect while taking it
A clinician can assess symptom severity, discuss preferences, and recommend a personalized plan, whether that means therapy referrals, medication, or both
doi: 10.2337/DB12-0432/-/DC1 45 MartinsCPNewLAOConnorECPreviteDMCargillKRTseILet al